summari due report result dec check
suggest overal contact len market remain healthi
grow rel consist market
expect mostli in-lin quarter total sale
growth ep consist
consensu forecast respect term
coopervis sale growth momentum expect
guid conserv lower end rang
start year light increas competit
us market uncertainti macro environ europ
manag target low double-digit ex-fx oper incom
growth ex-misight invest could prove challeng
estim step tax rate magnitud
impact misight spend depend time fda approv
could post call could give ep
guidanc without addit misight spend expect
manag call potenti impact either way
current forecast total sale consensu
growth ep penni consensu
report growth bullish commerci prospect
misight remain posit share compani
cusp new product approv potenti major new categori
expect mostli in-lin forecast total sale
growth ep essenti in-lin
consensu estim respect model
sale pro forma growth consist
growth ytd despit tougher comp
expect net stock benefit ahead consumpt tax
hike japan oct destock oct possibl
impact competitor call stock
benefit japan result end sep csi model
sale pro forma growth consist
growth deceler ytd due tougher comp
csi forecast includ paragard sale flat yr/yr
recent took price increas paragard may led
buy-in could boost sale tax rate
estim consist coo
histor trend tax rate tick
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani data secur llc estim reuter
continu previou page
fx headwind appear somewhat wors neutral latest fx analysi
suggest currenc headwind somewhat wors compar month ago
math point potenti increment top-lin pressur ep drag cent look
estim fx remain slightli neg coo top-lin growth essenti
neutral bottom-lin analysi show fx drag flow top-lin
essenti off-set currenc benefit gbp cog line worth note weaken
gbp relat brexit uncertainti could benefit coo cog overal ep assum
see posit sale growth momentum continu call manag state
sale continu grow next year still target low double-digit
oper incom growth ex-fx exclud invest misight launch top-lin
increas competit us market potenti macro headwind europ see
growth guidanc closer low-end rang csi believ low- mid-singl
digit sale growth reason current forecast total sale
consensu ex-fx growth
misight spend expect weigh ep guidanc estim higher misight spend
could total estim pre-launch spend would reduc oper
incom growth low-doubl digit high-singl digit bottom-lin addit
headwind relat higher misight spend also face expect
increas tax rate histor estim expect lower interest
expens help partli off-set tax rate increas estim net impact drag ep
growth net-net full misight spend materi addit off-set higher tax rate coo
ep growth may mid- high-singl digit rang howev actual magnitud impact
higher misight spend depend time fda approv may call
could give guidanc without addit misight invest depend time
approv would expect manag call impact either scenario overal expect
guid conserv especi earli point year estim ep
consensu report growth forecast includ higher tax rate lower
interest expens reflect full impact increas misight spend
remain bullish misight long-term outlook sens manag remain
optimist possibl fda approv misight myopia manag end
compani continu believ strength clinic data support approv recent
consult call reinforc favor view misight could approv later year earli next year
view remain misight meaning long-term opportun although commerci adopt
take time due logist roll fit set well educ market develop effort
misight consult believ us approv could help acceler ou adopt
product halo effect rest us contact len portfolio detail note
misight us misight approv like soon signific opportun ahead date addit
nei nation institut co-sponsor blink bifoc lens nearsight assess
coo biofin multifoc mf contact len prevent myopia progress studi complet
year accord clinicaltri gov data could present next year posit could
ultim pursu biofin mf approv myopia manag would add sihi len misight
non-sihi myopia manag portfolio
updat us sihi silicon hydrogel daili contact len competit landscap alc recent
launch newest sihi daili precis us continu ramp product broader
roll initi physician feedback gener posit comfort similar
price closer coo myday figur expect gain share competitor
like coo myday clariti also cannib alc optix dacp daili aquacomfort
addit tangibl scienc vsp optic recent launch unitybiosync sihi daili len
hydramist avail ecp eyecar profession vsp global premier program
understand unitybiosync sihi daili limit commerci
success accord consult final bhc continu target launch sihi daili aqualox
us although full launch may due product capac despit increas
competit believ coo clariti maintain competit advantag still sihi daili
us avail sphere multifoc toric
bhc report slower contact len sale growth report adjust sale
growth adjust stock relat japan consumpt tax repres deceler
adjust bhc report sale growth growth
stack basi growth also slow somewhat compani compar
channel check indic overal market seem remain healthi suggest
volatil growth recent quarter may reflect inventori chang relat brexit uncertainti
price target nc
price target base ep estim risk includ slower growth
contact len market increas competit stronger dollar
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis tie player nearli share billion global soft contact len
market revenu grew pro forma billion million
rebat cost annual total total oasi oasi astigamatismjohnson toricth multifocalth silicon hydrogel daili aquacomfort dacp except precis physician sourc myday toric costco com secur llc origin averag includ exclud acuvu oasi astigamat calcul base origin price/box assum lens per day exclud qualifi rebat subscript discount futur promot order new custom order order price avail precis price physician sourc myday toric price list costco com medic technolog
